Browse Category

Stock Market News 30 January 2026

Bank of America stock jumps 2.5% as rate bets shift; Friday’s catalysts in focus

Bank of America stock jumps 2.5% as rate bets shift; Friday’s catalysts in focus

Bank of America shares rose 2.45% to $53.08 after the Federal Reserve held rates steady. Investors await President Trump’s pick to replace Fed Chair Jerome Powell, set for Friday morning, which could shift rate cut expectations. A U.S. judge ruled Bank of America must face part of a class action over ties to Jeffrey Epstein, with trial set for May 11. JPMorgan and Wells Fargo also posted gains.
30 January 2026
Snowflake stock slides nearly 8% in software rout; traders brace for next catalyst

Snowflake stock slides nearly 8% in software rout; traders brace for next catalyst

Snowflake shares fell 7.7% to $199.37 Thursday, tracking a sharp selloff in software stocks amid fears that AI could disrupt subscription-based models. The S&P 500 Software and Services Index dropped 8.7% to a nine-month low. Snowflake’s recent launch of an energy-focused data package failed to offset sector-wide concerns. No new financial results were released by the company this week.
30 January 2026
Boston Scientific stock snaps a 4-day run — what to watch before Feb. 4 earnings

Boston Scientific stock snaps a 4-day run — what to watch before Feb. 4 earnings

Boston Scientific shares fell 1.6% to $92.33 Thursday, ending a four-day rally on heavy volume after the company completed its acquisition of Nalu Medical. The stock underperformed sector peers as investors awaited fourth-quarter results due Feb. 4 and looked for updates on recent deal activity, including the $14.5 billion Penumbra purchase.
Palo Alto Networks stock drops after Chronosphere deal closes, with earnings next in focus

Palo Alto Networks stock drops after Chronosphere deal closes, with earnings next in focus

Palo Alto Networks shares fell 4.8% to $174.85 Thursday after closing its $3.35 billion acquisition of observability firm Chronosphere. The stock edged up to $176.20 in after-hours trading. Investors are watching for Palo Alto’s Feb. 12 earnings report for updates on integration and the deal’s impact.
Eli Lilly stock barely budges after $1.93bn autoimmune pact; Trump touts six U.S. plants

Eli Lilly stock barely budges after $1.93bn autoimmune pact; Trump touts six U.S. plants

Eli Lilly shares closed up 0.03% at $1,024.14 after announcing new research deals in autoimmune disease and gene-editing for hearing loss. Repertoire Immune Medicines will receive $85 million upfront in a collaboration potentially worth $1.84 billion. Lilly also signed a gene-editing agreement with Seamless Therapeutics valued up to $1.12 billion. Investors await Feb. 4 earnings for updates on demand and supply.
Southwest Airlines stock jumps nearly 19% as LUV targets $4 profit — what traders watch next

Southwest Airlines stock jumps nearly 19% as LUV targets $4 profit — what traders watch next

Southwest Airlines shares jumped 18.7% Thursday to $48.50 after the company projected 2026 adjusted earnings of at least $4.00 per share, beating Wall Street estimates. The airline also forecast first-quarter unit revenue to rise at least 9.5% year over year. Southwest’s rally followed the rollout of assigned seating and new fee options. Investors await the company’s April quarterly report.
30 January 2026
Joby Aviation stock slides after $1.2 billion deal; dilution and hedging now in focus

Joby Aviation stock slides after $1.2 billion deal; dilution and hedging now in focus

Joby Aviation shares plunged 16.8% to $11.14 after the company announced a $1.2 billion stock and convertible note offering, including $600 million in 0.75% notes due 2032. The deal, upsized from $1 billion, will settle Feb. 2. Traders focused on the impact of new share supply and hedging activity tied to the convertible notes. Other eVTOL stocks also fell, but Joby’s drop was steeper.
30 January 2026
Bloom Energy stock drops 5% as Barclays initiation puts spotlight on valuation ahead of earnings

Bloom Energy stock drops 5% as Barclays initiation puts spotlight on valuation ahead of earnings

Bloom Energy shares fell 5.4% Thursday to $156.53 after Barclays initiated coverage with an Equalweight rating and a $153 target. The drop followed a recent surge to a 52-week high and volatility in leveraged ETFs tied to the stock. Bloom’s gains this month were fueled by a $2.65 billion utility order from American Electric Power. The company will report fourth-quarter 2025 results soon.
KLA stock whipsaws after earnings; KLAC rebounds in after-hours trade

KLA stock whipsaws after earnings; KLAC rebounds in after-hours trade

KLA Corp shares jumped 4% to $1,684.71 in after-hours trading Thursday after posting fiscal Q2 revenue of $3.30 billion and adjusted EPS of $8.85, both above Wall Street estimates. The company forecast March-quarter revenue near $3.35 billion and adjusted EPS around $9.08. Investors watched the outlook for signs of AI chip-tool demand. The stock had swung 7% lower before rebounding.
Applied Materials stock price steadies near $341 after ASML’s order surge — here’s what traders watch next

Applied Materials stock price steadies near $341 after ASML’s order surge — here’s what traders watch next

Applied Materials rose 1.4% to $341.34 at Thursday’s close after trading between $329 and $348. The move followed ASML’s record €13.2 billion in new orders and a raised 2026 sales forecast, which lifted chip-equipment stocks. AMAT reports fiscal Q1 results Feb. 12 and holds its shareholder meeting March 12. Trading volume reached about 7.3 million shares.
Goldman Sachs stock edges up as Big Tech jitters hit Wall Street — what’s next for GS

Goldman Sachs stock edges up as Big Tech jitters hit Wall Street — what’s next for GS

Goldman Sachs shares rose 0.2% to $940.12 after a volatile session, trading between $925.30 and $954.30 on volume near 2.3 million. The S&P 500 fell 0.13% and the Nasdaq dropped 0.72%, pressured by Microsoft’s 10% slide. Markets await inflation data and news on the Fed chair nomination Friday. Goldman filed for new five-year notes and led a $200 million IPO for Ethos Technologies.
30 January 2026

Stock Market Today

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
Go toTop